bromocriptine has been researched along with apomorphine in 249 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 189 (75.90) | 18.7374 |
| 1990's | 42 (16.87) | 18.2507 |
| 2000's | 14 (5.62) | 29.6817 |
| 2010's | 4 (1.61) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaton, A; Stadler, PA; Stütz, PL; Vigouret, JM | 1 |
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Bouthenet, ML; Giros, B; Martres, MP; Schwartz, JC; Sokoloff, P | 1 |
| Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD | 1 |
| Anderson, PS; Baldwin, JJ; Clineschmidt, BV; Hirshfield, JM; Jones, JH; Lundell, GF; Martin, GE; McClure, DE; Randall, WC; Williams, M | 1 |
| Anlezark, G; Law, SJ; Meldrum, B; Neumeyer, JL; Watling, KJ | 1 |
| Griffon, N; Lévesque, D; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
| Emms, F; Freedman, SB; Knowles, MR; Marwood, R; McAllister, G; Patel, S; Seabrook, GR | 1 |
| Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
| Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Quik, M; Sourkes, TL | 1 |
| Goldstein, M; Hata, F; Lew, JY; Ohashi, T | 1 |
| Männistö, PT; Ranta, T | 1 |
| Beckmann, H | 1 |
| Hungerbühler, JP; Regli, F | 1 |
| Rinne, UK | 1 |
| Parkes, JD | 1 |
| Agnati, LF; Coyle, JT; Fuxe, K; Hökfelt, T; Schwarcz, R | 1 |
| Bo, P; Savoldi, F; Tartara, A | 3 |
| Danzeisen, M; Gygax, P; Meier-Ruge, W; Wiernsperger, N | 1 |
| Szabo, S | 1 |
| Hicks, PB; Samorajski, T; Smith, RC; Strong, JR | 1 |
| Sparber, SB; Tolosa, ES | 1 |
| Carruba, MO; Mantegazza, P; Picotti, GB; Tofanetti, O | 1 |
| Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Parati, EA | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Smelik, PG; Tilders, FJ | 1 |
| Dent, R; Guyda, H; Tolis, G | 1 |
| Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL | 1 |
| Männistö, P; Ranta, T; Tuomisto, J | 1 |
| List, SJ; Seeman, P | 1 |
| Gluckman, PD; Grumbach, MM; Kaplan, SL; Marti-Henneberg, C; Rudolph, AM; Thomsett, MJ | 1 |
| Farjo, IB; McQueen, JK | 1 |
| Agnati, L; Fuxe, K; Köhler, C; Ogren, SO | 1 |
| Danzeisen, M; Gygax, P; Schweizer, A; Wiernsperger, N | 1 |
| Camerman, A; Camerman, N; Chan, LY | 1 |
| Jaton, AL; Loew, DM; Vigouret, JM | 1 |
| Kanapa, DJ; Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Pfeiffer, RF; Silbergeld, EK | 1 |
| Di Chiara, G; Gessa, GL; Porceddu, ML; Vargiu, L | 1 |
| Anlezark, GM; Horton, RW; Meldrum, BS | 1 |
| Banovac, K; Petek, M; Sekso, M; Solter, M; Vizner, B | 1 |
| di Chiara, G; Gessa, GL; Porceddu, ML; Stefanini, E; Vargiu, L | 1 |
| Barbeau, A; Bélanger, F; Butterworth, RF | 1 |
| Johnels, B; Steg, G; Ungerstedt, U | 1 |
| Bioulac, B; Ferron, A; Fumoux, F; Vincent, JD | 1 |
| Horowski, R | 1 |
| Seeman, P; Titeler, M | 1 |
| Gala, RR; Jaques, S | 1 |
| Pohto, P | 1 |
| Bartolini, A; Mantovani, P; Pepeu, G | 1 |
| Bunney, WE | 1 |
| Bianchi, S; Consolo, S; Ghezzi, D; Ladinsky, H | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Dickey, RP; Stone, SC | 1 |
| Calne, DB; Claveria, LE; Reid, JL | 1 |
| Handforth, A; Sourkes, TL | 1 |
| Diederich, NJ; Goetz, CG | 1 |
| Samini, M; Shokravi, S; Zarrindast, MR | 1 |
| Carlsson, A; Carlsson, ML; Svensson, A | 1 |
| Dutt, A; Juneja, HS | 1 |
| Levivier, M; Przedborski, S | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Demichel, P; Moran, A; Roquebert, J; Sauvage, MF | 1 |
| Minaian, A; Zarrindast, MR | 1 |
| Eliassi, A; Zarrindast, MR | 1 |
| Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM | 1 |
| Ackman, CF; Assalian, P; Kiely, ME; Lal, S; Stewart, JD; Thavundayil, JX | 1 |
| Cespuglio, R; Chastrette, N; Jouvet, M; Lin, YL | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| Haba, K; Mizukawa, K; Ogawa, N; Sato, H | 1 |
| Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A | 1 |
| Khanna, N; Ray, A; Sen, P | 1 |
| Barone, D; Benedetti, MS; Dostert, P; Efthymiopoulos, C; Peretti, G; Roncucci, R | 1 |
| Kuramoto, S; Ohtsuru, K; Torigoe, R; Yoshida, M | 1 |
| Alaoui, K; Morán, A; Roquebert, J | 1 |
| Shahed-Dirin, K; Zarrindast, MR | 1 |
| Carboni, E; Carruba, MO; Memo, M; Spano, PF; Trabucchi, M | 1 |
| Klimek, V; Nikulina, EM; Popova, NK | 1 |
| Campastro, OJ; D'Anna, L; Fernández, RA; González, SA; Loidl, CF; Pecci-Saavedra, J; Soqueff, MN | 1 |
| Anderson, SM; Schaeffer, JM | 1 |
| Poursoltan, M; Zarrindast, MR | 1 |
| Benabid, AL; Champay, AS; Hommel, M; Perret, JE; Pollak, P | 1 |
| Beart, PM; Cook, CJ; Hashizume, M; Jackson, DM; Tabar, J | 1 |
| Baldessarini, RJ; Campbell, A; Cremens, C; Kula, NS; Marsh, E; Teicher, MH | 1 |
| Tissari, AH | 2 |
| Barton, AC; Demarest, KT; Moore, KE | 1 |
| Hollister, LE | 1 |
| Hara, T; Kishimoto, O; Mizuki, Y; Soeda, K; Ushijima, I; Yamada, M | 1 |
| Martinez-Mir, I; Morales-Olivas, FJ; Rubio, E | 1 |
| Hashizume, M; Jackson, DM; Ross, SB | 1 |
| Chagraoui, A; Protais, P; Vasse, M | 1 |
| Anokhina, IP; Ivanets, NN; Nebarakova, TP; Reshchikova, EV | 1 |
| Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M | 1 |
| Cubeddu, LX; Hoffmann, IS; Talmaciu, RK | 1 |
| Greer, NL; Schechter, MD | 1 |
| Delbende, C; Jégou, S; Pelletier, G; Tranchand-Bunel, D; Vaudry, H | 1 |
| Jin, GZ; Le, WD; Zhou, XD | 1 |
| Butterfield, J; Garrard, JM; Peterson, DA | 1 |
| Boccuni, M; Cangi, F; Del Bene, E; Fusco, BM; Sicuteri, F | 1 |
| Feuerstein, TJ; Hertting, G; Jackisch, R; Moll, S | 1 |
| Collu, R; Ducharme, JR; Lafond, J | 1 |
| Handelsman, DJ; Jarjour, LT; Raum, WJ; Swerdloff, RS | 1 |
| Rose, PA; Weick, RF | 1 |
| Ekker, M; Sourkes, TL | 1 |
| Fahn, S; Hassan, MN; Higgins, D; Traub, M | 1 |
| Cekan, S; Goiny, M; Uvnäs-Moberg, K | 2 |
| Martínez, JA; Milanés, MV; Vargas, ML | 1 |
| Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
| Mizuki, Y; Ushijima, I; Yamada, M | 1 |
| D'Angelo, L; Fernández, M; Hawkins, M; Jantos, H; Monti, JM | 1 |
| Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG | 1 |
| Turner, TH | 1 |
| Block, H; Klemm, WR | 1 |
| Hoffmann, W; Stelzig, S | 1 |
| Carvey, P; Goetz, CG; Klawans, HL; Paulseth, JE | 1 |
| Biziere, K; Gueudet, C; Worms, P | 1 |
| Ackman, D; Blundell, P; Gardiner, RJ; Lal, S; Laryea, E; Nair, NP; Negrete, J; Thavundayil, JX | 1 |
| Cherchi, A; Gessa, GL; Mercuro, G; Rivano, AC; Rossetti, Z; Ruscazio, M; Stefanini, E; Tocco, L | 1 |
| Ozaki, L; Stern, N; Tuck, ML | 1 |
| Jackson, DM; Jenkins, OF | 1 |
| Bantutova, I; Iakimova, K; Koleva, E; Ovcharova, R | 1 |
| Casey, DE | 1 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Hardie, RJ; Lees, AJ; Stern, GM | 1 |
| Boiadzhieva, N; Ovcharov, R; Zakharieva, B | 1 |
| Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E | 1 |
| Fahn, S; Hassan, M; Jackson-Lewis, V; Traub, M; Wagner, HR | 1 |
| Meldrum, BS; Naquet, R | 1 |
| Eguíbar, JR; Holmgren, B; Trucios, N; Urbá-Holmgren, R; Zermeño, M | 1 |
| Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E | 1 |
| Dóda, M; György, L | 3 |
| Burton, K; Calne, DB | 1 |
| Buylaert, WA; Green, AR; Heal, DJ | 1 |
| Jenner, P; Marsden, CD; Reavill, C | 1 |
| Agnati, LF; Andersson, K; Fredholm, B; Fuxe, K; Hall, H; Köhler, C; Ogren, SO | 1 |
| Carruba, MO; Mantegazza, P; Müller, EE; Ricciardi, S | 1 |
| Lideman, RR; Mukhin, AG; Zlobina, GP | 1 |
| Gianutsos, G; Moore, KE | 1 |
| Tufik, S | 1 |
| Andreeva, OG; Korovin, KF; Ostroumova, MN; Schelkunov, EL | 1 |
| Flückiger, E; Vigouret, JM | 1 |
| Costall, B; Lim, SK; Naylor, RJ | 1 |
| Bergmann, F | 1 |
| Dusticier, N; Kerkerian, L; Nieoullon, A | 1 |
| Briley, M; Langer, SZ; Lehmann, J | 1 |
| De Sarro, A; Ientile, R; Nistico, G; Pujia, A; Urna, G | 1 |
| Maeda-Hagiwara, M; Watanabe, K | 2 |
| Ferrer, JM; Mora, F; Sanguinetti, AM; Vives, F | 1 |
| de Belleroche, J; Gardiner, IM | 1 |
| Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP | 1 |
| Bendesky, RJ; Martin, GE | 1 |
| Kurako, IuL; Volianskiĭ, VE | 1 |
| Denef, C; Dewals, R; Manet, D | 1 |
| Cronin, MJ; Faure, N; Martial, JA; Weiner, RI | 1 |
| Levitin, HP; Mezzadri-Levitin, MR | 1 |
| Király, I; Van Ree, JM | 1 |
| Caraceni, TA; Giovannini, P; Girotti, F; Parati, EA; Pederzoli, M | 1 |
| Dóda, M; Folly, G; György, L; Orr, Z | 1 |
| Gluckman, PD; Grumbach, MM; Kaplan, SL | 1 |
| Laakso, K; Laihinen, A; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK | 1 |
| Globus, M; Melamed, E | 1 |
| Ginos, JZ; Goldberg, LI; Woolverton, WL | 1 |
| Denucé, JM; Meijer, RC; Schoots, AF | 1 |
| Bowden, DM; Dooley, DJ | 1 |
| Koulu, M; Lammintausta, R | 1 |
| Dieguez, C; Foord, SM; Hall, R; Jasani, B; Peters, JR; Scanlon, MF | 1 |
| Brozmanová, H; Földes, O; Gschwendtová, K; Langer, P; Mess, B; Ruzsás, C; Straussová, K | 1 |
| Chang, JP; Nahorniak, CS; Peter, RE; Sokolowska, M | 1 |
| Wang, RY; White, FJ | 1 |
| Bisgard, GE; Nielsen, AM | 1 |
| Ackman, D; Etienne, P; Kiely, ME; Lal, S; Thavundayil, JX | 1 |
| Cutler, NR; Jeste, DV; Karoum, F; Kaufmann, CA | 1 |
| Karson, CN | 1 |
| Gietzen, DW; Hope, WG; Woolley, DE | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Carroll, BJ; Katz, RJ; Steiner, M | 1 |
| Hruska, RE; Silbergeld, EK; Weir, RL | 1 |
| Bethea, CL; Jaffe, RB; Ramsdell, JS; Weiner, RI; Wilson, CB | 1 |
| Cowan, A; Porreca, F; Tallarida, RJ | 1 |
| Bannet, J; Belmaker, RH; Globus, M; Lerer, B | 1 |
| Dieguez, C; Foord, SM; Hall, R; Peters, JR; Scanlon, MF | 1 |
| Cubeddu, LX; Hoffmann, IS; James, MK; Niedzwiecki, DM | 1 |
| Lee, RJ; Lomax, P | 1 |
| Lang, WJ; Rechtman, MP; Woodman, OL | 1 |
| McDevitt, JT; Setler, PE | 1 |
| Agnati, LF; Fuxe, K | 1 |
| Cubeddu, LX; Hoffman, IS | 1 |
| Heninger, GR; Kendler, KS; Roth, RH | 1 |
| Muscholl, E; Racké, K; Ritzel, H; Trapp, B | 1 |
| Johnels, B; Steg, G | 1 |
| Johnels, B | 1 |
| Blomquist, L; Goiny, M; Posloncec, B; Uvnäs-Moberg, K | 1 |
| Finch, CE; Randall, PK; Severson, JA | 1 |
| Fernández Pardal, MM; Leiguarda, RC; Micheli, F | 1 |
| Boismare, F; Leclerc, JL; Moore, N; Saligaut, C | 1 |
| Stewart, RM | 1 |
| Kehr, W | 1 |
| Woolf, PD | 1 |
| Fang, VS | 1 |
| Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO | 1 |
| Camerman, A; Camerman, N | 1 |
| Consolo, S; Crunelli, V; Fusi, R; Ladinsky, H; Pugnetti, P | 1 |
| Malarkey, WB; Tallo, D | 1 |
| Dóda, M; György, L; Orr, Z | 1 |
| Robertson, HA | 1 |
| Agnoli, A; Ciancarelli, G; Forchetti, C; Pacitti, C; Scarnati, E | 1 |
| Rauca, C; Schröder, H | 1 |
| Kulkarni, SK; Verma, A | 1 |
| Levavi-Sivan, B; Ofir, M; Yaron, Z | 1 |
| Gueudet, C; Gully, D; Le Fur, G; Poncelet, M; Soubrié, P; Souilhac, J; Terranova, JP | 1 |
| Jaehkel, M; Oehler, J; Schumacher, HE | 1 |
| Kamijo, N; Nagao, T; Ono, H | 1 |
| Conway, SB; Gietzen, DW; Hope, WG; Thompson-Reece, MA; Woolley, DE | 1 |
| Conceição, IM; Frussa-Filho, R | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Carriero, DL; Cousins, MS; Salamone, JD | 1 |
| Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H | 1 |
| Dzaja, P; Grabarević, Z; Kos, J; Perić, J; Rotkvić, I; Seiwerth, S; Sikirić, P | 1 |
| Dehpour, AR; Samini, M; Yousefnejad, S | 1 |
| Bani-Assadi, S; Ghazi-Khansari, M; Rezvani, N; Zarrindast, MR | 1 |
| Doğrul, A; Yeşilyurt, O | 1 |
| Factor, SA | 1 |
| Chang, A; Shin, SH | 1 |
| Cumps, J; Geurts, M; Hermans, E; Maloteaux, JM | 1 |
| Fukuda, T; Iwata, S; Kaseda, S; Nomoto, M; Shimosaka, M; Tanoue, S | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Fu, D; Javitch, JA; Lin, H; Strange, PG; Wilson, J | 1 |
| Jankovic, J; Le, WD | 1 |
| Kim, IH; Lee, YG; Lim, DY | 1 |
| Bravo, G; Centurión, D; Ramírez-San Juan, E; Sánchez-López, A; Saxena, PR; Villalón, CM; Willems, EW | 1 |
| Adamik, A; Jászberényi, M; Mácsai, M; Pataki, I; Telegdy, G | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Katsuragi, T; Kita, S; Morishita, H; Sakata, N; Shibata, K | 1 |
| Itoh, H; Kurachi, M; Sumiyoshi, T; Uehara, T | 1 |
| Andersohn, F; Garbe, E | 1 |
| Fujinami, A; Ikeda, E; Inoue, S; Kuno, S; Ohta, K; Ohta, M | 1 |
| Kumar, JB; Luthra, PM | 1 |
20 review(s) available for bromocriptine and apomorphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
Bromocriptine in the treatment of parkinsonism.
Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior | 1979 |
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine | 1979 |
Drugs that affect the breast and lactation.
Topics: Androgens; Apomorphine; Barbiturates; Breast; Breast Neoplasms; Bromocriptine; Contraceptives, Oral, Hormonal; Estrogens; Female; Galactorrhea; Humans; Lactation; Levodopa; Male; Monoamine Oxidase Inhibitors; Nandrolone; Phenothiazines; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Pyridoxine; Steroids | 1975 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
[Current therapeutic approach in Parkinson disease].
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E | 1992 |
[Dopaminergic disequilibria in hemicrania].
Topics: Animals; Apomorphine; Blood Pressure; Brain; Bromocriptine; Domperidone; Dopamine; Heart Rate; Humans; Lisuride; Mice; Migraine Disorders; Posture; Rats; Sexual Behavior; Sulpiride; Synaptic Transmission; Tiapamil Hydrochloride | 1985 |
The controversial role of bromocriptine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Time Factors | 1985 |
[Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Topics: Adenylyl Cyclase Inhibitors; Animals; Antipsychotic Agents; Apomorphine; Blood Platelets; Brain; Bromocriptine; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Humans; Methyltyrosines; Rats; Receptors, Dopamine; Receptors, Opioid; Schizophrenia; Synaptic Membranes; Synaptic Transmission | 1980 |
Central dopamine receptors.
Topics: Acetylcholine; Animals; Apomorphine; Brain; Bromocriptine; Cats; Cattle; gamma-Aminobutyric Acid; In Vitro Techniques; Mice; Prolactin; Rats; Receptors, Dopamine; Substantia Nigra; Tyrosine 3-Monooxygenase | 1981 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus.
Topics: Amniotic Fluid; Anencephaly; Animals; Apomorphine; beta-Endorphin; Bromocriptine; Endorphins; Estradiol; Estrogens; Female; Fetus; Follicle Stimulating Hormone; Growth Hormone; Haloperidol; Humans; Hypothalamus; Luteinizing Hormone; Pituitary Gland; Pregnancy; Prolactin; Serotonin; Species Specificity; Thyrotropin-Releasing Hormone | 1981 |
On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Bromocriptine; Humans; Hydroxydopamines; Levodopa; Receptors, Dopamine | 1980 |
New directions in the drug treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline | 1996 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Drug Delivery Systems; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine | 2012 |
3 trial(s) available for bromocriptine and apomorphine
| Article | Year |
|---|---|
Apomorphine-induced penile tumescence in impotent patients--preliminary findings.
Topics: Adult; Apomorphine; Bromocriptine; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Prognosis; Prolactin | 1987 |
Effects of DA agonist in Huntington disease hyperkinesia.
Topics: Adult; Apomorphine; Bromocriptine; Clinical Trials as Topic; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Huntington Disease; Lisuride; Male; Middle Aged | 1980 |
Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
Topics: Adult; Apomorphine; Benztropine; Bromocriptine; Cholinergic Fibers; Dopamine; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Penis | 1984 |
226 other study(ies) available for bromocriptine and apomorphine
| Article | Year |
|---|---|
Ergot alkaloids. New ergolines as selective dopaminergic stimulants.
Topics: Animals; Corpus Striatum; Embryo Implantation; Ergolines; Female; Humans; Hydroxydopamines; Male; Motor Activity; Prolactin; Rats; Receptors, Dopamine; Stereoisomerism; Stereotyped Behavior; Substantia Nigra | 1978 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line; Cloning, Molecular; Cricetinae; DNA; DNA Restriction Enzymes; Dopamine; Guanylyl Imidodiphosphate; Molecular Sequence Data; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sequence Homology, Nucleic Acid; Tissue Distribution | 1990 |
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri | 1986 |
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists.
Topics: Animals; Apomorphine; Cattle; Cerebral Cortex; Clonidine; Dopamine; Hydroxydopamines; Indicators and Reagents; Models, Molecular; Molecular Conformation; Motor Activity; Oxazines; Oxidopamine; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Rotation; Structure-Activity Relationship | 1984 |
Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Aporphines; Chemical Phenomena; Chemistry; In Vitro Techniques; Mice; Papio; Photic Stimulation; Seizures | 1981 |
A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
Topics: Animals; CHO Cells; Cricetinae; Dopamine Agents; Humans; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1995 |
Expression and pharmacological characterization of the human D3 dopamine receptor.
Topics: Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; GTP-Binding Proteins; Guanine Nucleotides; Humans; Potassium Channels; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Second Messenger Systems; Sulpiride | 1994 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin | 2002 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase | 1977 |
Neurotransmitter control of thyrotrophin secretion in hypothyroid rats.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonidine; Ditiocarb; Fenclonine; Hypothyroidism; Male; Methyltyrosines; Neurotransmitter Agents; Phenoxybenzamine; Pimozide; Piribedil; Pituitary Gland, Anterior; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Thyroid Gland; Thyrotropin; Tryptophan | 1978 |
[Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
Topics: Acute Disease; Amphetamines; Antipsychotic Agents; Apomorphine; Blood Platelets; Bromocriptine; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Humans; Male; Monoamine Oxidase; Neurons; Phenelzine; Psychotropic Drugs; Schizophrenia; Tranylcypromine | 1978 |
Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Corpus Striatum; Denervation; Dominance, Cerebral; Efferent Pathways; Ergolines; Humans; Hydroxydopamines; Kainic Acid; Male; Pyrrolidines; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1979 |
Antagonism between dopaminergic and neuroleptic drugs. I. Acute administration.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arousal; Bromocriptine; Central Nervous System; Chlorpromazine; Dibenzothiazepines; Electroencephalography; Haloperidol; Neurotransmitter Agents; Piribedil; Rabbits; Reserpine | 1979 |
Antagonism between dopaminergic and neuroleptic drugs. II. Chronic administration.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arousal; Bromocriptine; Central Nervous System; Chlorpromazine; Dibenzothiazepines; Electroencephalography; Haloperidol; Neurotransmitter Agents; Piribedil; Rabbits; Time Factors | 1979 |
Improvement of brain tissue oxygenation during cerebrovascular insufficiency by interfering with the catecholaminergic system.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Blood Volume; Brain; Bromocriptine; Cats; Cerebrovascular Disorders; Ergolines; Oxygen; Phenoxybenzamine | 1979 |
Dopamine disorder in duodenal ulceration.
Topics: Animals; Anti-Ulcer Agents; Apomorphine; Bromocriptine; Chemical Phenomena; Chemistry; Cysteamine; Dopamine; Drug Synergism; Duodenal Ulcer; Ergolines; Female; Gastric Juice; Haloperidol; Pimozide; Rats; Receptors, Dopamine | 1979 |
Behavioral evidence for supersensitivity after chronic bromocriptine administration.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Drug Tolerance; Female; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine; Stereotyped Behavior | 1979 |
Huntington chorea.
Topics: Apomorphine; Bromocriptine; Humans; Huntington Disease | 1977 |
Involvement of serotoninergic neurons in the hyperthermic response to dopaminergic agonists.
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Dextroamphetamine; Dihydroxytryptamines; Dopamine; Fenclonine; Male; Neurons; Rabbits; Serotonin; Time Factors | 1978 |
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
Topics: Adult; Apomorphine; Bromocriptine; Female; Growth Hormone; Humans; Huntington Disease; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Receptors, Dopamine | 1979 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats.
Topics: Animals; Apomorphine; Brain Mapping; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Hypothalamo-Hypophyseal System; Male; Melanocyte-Stimulating Hormones; Pimozide; Pituitary Gland; Rats; Synaptic Transmission; Time Factors; Water-Electrolyte Balance | 1978 |
Opiates, prolactin, and the dopamine receptor.
Topics: Apomorphine; Bromocriptine; Chlorpromazine; Cyproheptadine; Heroin Dependence; Humans; Kinetics; Levodopa; Methadone; Morphine; Prolactin; Receptors, Dopamine | 1978 |
Evidence for dopaminergic control of thyrotrophin secretion in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Cold Temperature; Dopamine; Male; Pimozide; Rats; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone | 1979 |
Hormone ontogeny in the ovine fetus. VI. Dopaminergic regulation of prolactin secretion.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Bromocriptine; Dopamine; Female; Fetus; Gestational Age; Haloperidol; Pregnancy; Prolactin; Sheep | 1979 |
Dopamine agonists and cobalt-induced epilepsy in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Cobalt; Dopamine; Electroencephalography; Hydroxydopamines; Lisuride; Male; Pimozide; Rats; Receptors, Dopamine; Seizures | 1979 |
Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone.
Topics: Animals; Apomorphine; Binding Sites; Binding, Competitive; Brain; Bromocriptine; Butyrophenones; In Vitro Techniques; Male; Rats; Spiperone | 1979 |
Dopaminergic agonists and their influence on the oxygenation and function activity of underperfused brain tissue.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Cats; Dopamine; Electroencephalography; Electrophysiology; In Vitro Techniques; Oxygen Consumption; Perfusion; Shock, Hemorrhagic | 1979 |
Stereochemical characteristics of dopamine agonists: molecular structure of bromocriptine and structural comparisons with apomorphine.
Topics: Apomorphine; Bromocriptine; Crystallization; Models, Molecular; Molecular Conformation; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship | 1979 |
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Ergolines; Humans; Nitriles; Rats; Stereotyped Behavior | 1978 |
Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Dextroamphetamine; Guinea Pigs; Humans; Male; Parkinson Disease; Stereotyped Behavior | 1978 |
Dopamine-agonist drugs and cerebral electrical activity in the rabbit.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Cerebral Cortex; Evoked Potentials; Humans; Hypothalamus; Piperazines; Piribedil; Rabbits; Stereotyped Behavior; Thalamus | 1979 |
Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Topics: Acetonitriles; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Ergolines; Humans; Male; Methyltyrosines; Rats; Stereotyped Behavior | 1977 |
Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Drug Interactions; Ergolines; Mice; Motor Activity; Pimozide; Receptors, Dopamine; Stimulation, Chemical | 1977 |
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures | 1978 |
The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
Topics: Adult; Apomorphine; Bromocriptine; Chlorpromazine; Female; Humans; Levodopa; Pituitary Gland | 1977 |
Evidence for selective and long-lasting stimulation of "regulatory" dopamine-receptors by bromocriptine (CB 154).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Dopamine; Homovanillic Acid; Male; Mice; Motor Activity; Receptors, Dopamine; Stimulation, Chemical; Synaptosomes; Time Factors | 1977 |
Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Dopamine; Hydroxydopamines; Hypothalamus; Hypothalamus, Anterior; Levodopa; Male; Models, Neurological; Motor Activity; Norepinephrine; Piribedil; Rats; Receptors, Dopamine; Serotonin; Tyrosine | 1978 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Cats; Caudate Nucleus; Cerebral Cortex; Dopamine; Female; Male; Neurons; Piperazines; Piribedil; Rats; Time Factors | 1978 |
Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Dopamine; Drug Interactions; Ergot Alkaloids; Female; Lisuride; Lysergic Acid Diethylamide; Methyltyrosines; Mice; Reserpine; Sulpiride | 1978 |
Antiparkinsonian drug doses and neuroleptic receptors.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Cattle; Caudate Nucleus; Haloperidol; In Vitro Techniques; Receptors, Dopamine; Spiperone; Tritium | 1978 |
The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
Topics: Animals; Apomorphine; Bromocriptine; Castration; Ergolines; Female; Humans; Macaca fascicularis; Ovary; Perphenazine; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone; Time Factors | 1975 |
A neuropharmacological approach to experimental bruxism.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Bruxism; Drug Synergism; Levodopa; Male; Mastication; Methylphenidate; Piribedil; Rats; Scopolamine; Theophylline; Time Factors | 1977 |
Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Topics: Acetylcholine; Animals; Apomorphine; Benserazide; Bromocriptine; Cats; Cerebral Cortex; Dopamine; Female; Haloperidol; Levodopa; Male; Parasympathetic Nervous System; Rats; Time Factors | 1977 |
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia | 1977 |
Apparent lack of a dopaminergic-cholinergic link in the rat nucleus accumbens septi-tuberculum olfactorium.
Topics: Acetylcholine; Animals; Apomorphine; Bromocriptine; Chlorpromazine; Clozapine; Dextroamphetamine; Haloperidol; Nucleus Accumbens; Olfactory Bulb; Pimozide; Piribedil; Rats; Receptors, Cholinergic; Receptors, Dopamine; Septal Nuclei | 1977 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Hypothermic action of bromocriptine.
Topics: Amphetamine; Animals; Apomorphine; Body Temperature Regulation; Brain; Bromocriptine; Cold Temperature; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Environment, Controlled; Ergolines; Hypothermia; Male; Pimozide; Rats | 1975 |
Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Codeine; Depression, Chemical; Dopamine; Ergolines; Haloperidol; Hydroxybutyrates; Male; Naphthols; Piribedil; Rats | 1975 |
Editorial: Alternatives to levodopa.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease | 1976 |
Opposite influences of dopaminergic receptor subtypes on penile erection.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Parasympatholytics; Parasympathomimetics; Penile Erection; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1992 |
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Biogenic Monoamines; Bromocriptine; Dizocilpine Maleate; Dopamine Agents; Dopamine D2 Receptor Antagonists; Male; Methyltyrosines; Mice; Motor Activity; N-Methylaspartate; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Salicylamides; Tyrosine 3-Monooxygenase | 1992 |
Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Hypothalamus; In Vitro Techniques; Male; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Rats; Reserpine | 1992 |
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1991 |
Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart.
Topics: Acetylcholine; Animals; Apomorphine; Bradycardia; Bromocriptine; Decerebrate State; Dopamine Agents; Electric Stimulation; Ergolines; Heart; Heart Rate; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vagus Nerve | 1991 |
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming | 1991 |
Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Male; Methyltyrosines; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured | 1990 |
Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: an open study.
Topics: Adult; Apomorphine; Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged | 1991 |
Proopiomelanocortin (POMC)-derived peptides and sleep in the rat. Part 2--Aminergic regulatory processes.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; alpha-MSH; Animals; Apomorphine; Bromocriptine; Corticotropin-Like Intermediate Lobe Peptide; Dopamine; Dopamine Antagonists; Hypoxia; Male; Peptide Fragments; Pro-Opiomelanocortin; Rats; Receptors, Dopamine; Serotonin; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Tetrahydronaphthalenes | 1990 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Bromocriptine; Ceruletide; Dyskinesia, Drug-Induced; Levodopa; Male; Neurotoxins; Neurotransmitter Agents; Nitriles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic | 1990 |
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains | 1990 |
Possible prostaglandin-dopamine interactions during experimental gastric ulcer formation.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Indomethacin; Male; Prostaglandins; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1990 |
In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine.
Topics: Administration, Oral; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Cabergoline; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Female; In Vitro Techniques; Injections, Intravenous; Kinetics; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Corpus Striatum; Dominance, Cerebral; Drug Implants; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Thyrotropin-Releasing Hormone | 1990 |
Effect of bromocriptine on neurogenic vasoconstriction in the isolated autoperfused hindquarters of the rat.
Topics: Animals; Apomorphine; Bromocriptine; Hindlimb; Male; Perfusion; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Vasoconstriction | 1990 |
Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Methyltyrosines; Mice; Pimozide; Receptors, Dopamine; Reserpine; Sulpiride | 1990 |
Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Bromocriptine; Calcium; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Female; Ion Channels; Male; Neurotensin; Pituitary Gland; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
[Clopheline-induced aggression in mice: role of genotype and the dopaminergic system].
Topics: Aggression; Animals; Apomorphine; Bromocriptine; Clonidine; Flupenthixol; Genotype; Haloperidol; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
A novel, fully automated rotometer for the study of turning behavior. Comparison of results under different experimental conditions.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine Agents; Female; Hydroxydopamines; Kainic Acid; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1989 |
Dopamine stimulated increase of GTP levels in the rat retina.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Dopamine; Dose-Response Relationship, Drug; Female; Guanosine Triphosphate; Isomerism; Isoproterenol; Rats; Rats, Inbred Strains; Retina | 1985 |
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atropine; Behavior, Animal; Benzazepines; Bromocriptine; Drug Interactions; Male; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Theophylline; Yawning | 1989 |
Subcutaneous apomorphine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease | 1989 |
The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Body Temperature; Bromocriptine; Dextroamphetamine; Dopamine; Levodopa; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Dopamine; Stereotyped Behavior | 1989 |
Bromocriptine antagonizes behavioral effects of cocaine in the rat.
Topics: Animals; Apomorphine; Arousal; Bromocriptine; Circadian Rhythm; Cocaine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Reference Values; Septal Nuclei; Time Factors | 1989 |
Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
Topics: Animals; Apomorphine; Bromocriptine; Bucladesine; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Ouabain; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reference Values; Reserpine; Synaptosomes | 1988 |
Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
Topics: 4-Butyrolactone; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Ergolines; Limbic System; Male; Nucleus Accumbens; Olfactory Bulb; Prolactin; Rats; Time Factors | 1987 |
Novel drug treatments for schizophrenia.
Topics: Adrenergic Agonists; Antipsychotic Agents; Apomorphine; Bromocriptine; Humans; Neuropeptides; Receptors, Dopamine; Schizophrenia | 1987 |
Effects of age on behavioral responses to dopamine agonists in the rat.
Topics: Aging; alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine; Male; Methyltyrosines; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior; Tyrosine 3-Monooxygenase; Yawning | 1987 |
The lack of the effect of DA-1 and DA-2 dopamine agonists on the isolated guinea-pig atria.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Domperidone; Electric Stimulation; Female; Fenoldopam; Guinea Pigs; Heart; In Vitro Techniques; Male; Piribedil; Propranolol; Receptors, Dopamine; Vasodilator Agents | 1987 |
Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Bromocriptine; Drug Interactions; In Vitro Techniques; Male; Methyltyrosines; Mice; Motor Activity; Reserpine; Tyrosine 3-Monooxygenase | 1988 |
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Piribedil; Quinpirole; Receptors, Dopamine; Stereotyped Behavior | 1988 |
[Dopamine receptor stimulants in the treatment of alcoholism].
Topics: Alcoholism; Apomorphine; Bromocriptine; Dopamine; Dopamine Agents; Drug Evaluation; Ethanol; Humans; Male; Substance Withdrawal Syndrome | 1988 |
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1988 |
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Topics: Acetylcholine; alpha-Methyltyrosine; Animals; Apomorphine; Bromocriptine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Ergolines; Haloperidol; In Vitro Techniques; Methyltyrosines; Neurotransmitter Uptake Inhibitors; Nomifensine; Quinpirole; Rabbits; Receptors, Dopamine; Reserpine | 1986 |
Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sex Factors | 1987 |
Hypothalamic alpha-melanocyte-stimulating hormone (alpha-MSH) is not under dopaminergic control.
Topics: Animals; Apomorphine; beta-Endorphin; Bromocriptine; Dopamine; Haloperidol; Hypothalamus; In Vitro Techniques; Male; Melanocyte-Stimulating Hormones; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains | 1987 |
Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D-1 receptor binding.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior | 1988 |
The dopaminergic D receptor: another example of reductive activation?
Topics: Adenylyl Cyclases; Apomorphine; Bromocriptine; Chlorpromazine; Dopamine; Enzyme Activation; Haloperidol; Receptors, Dopamine; Receptors, Dopamine D1 | 1988 |
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dopamine; Electric Stimulation; Ergolines; Hippocampus; In Vitro Techniques; Norepinephrine; Quinpirole; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Serotonin; Yohimbine | 1985 |
Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
Topics: Animals; Apomorphine; Bromocriptine; Cell Cycle; Cyclic AMP; Dopamine; Female; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Sodium; Time Factors | 1986 |
Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Dopamine beta-Hydroxylase; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; Male; Norepinephrine; Phentolamine; Pimozide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1986 |
Hyperresponsiveness to the inhibitory action of dopamine agonists on luteinizing hormone secretion in the monosodium-L-glutamate-treated, orchidectomized rat.
Topics: Animals; Animals, Newborn; Apomorphine; Bromocriptine; Dopamine; Glutamates; Hypothalamus; Luteinizing Hormone; Male; Orchiectomy; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Sodium Glutamate; Synaptic Transmission | 1986 |
Decreased activity of adrenal S-adenosylmethionine decarboxylase in rats subjected to dopamine agonists, metabolic stress, or bodily immobilization.
Topics: Adenosylmethionine Decarboxylase; Adrenal Cortex; Adrenal Glands; Adrenal Medulla; Adrenocorticotropic Hormone; Animals; Apomorphine; Bromocriptine; Carboxy-Lyases; Cyclic AMP; Denervation; Deoxyglucose; Dopamine; Hypophysectomy; Insulin; Male; Piribedil; Rats; Rats, Inbred Strains; Restraint, Physical; Splanchnic Nerves; Stress, Physiological | 1987 |
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine Antagonists; Humans; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1986 |
Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
Topics: Animals; Apomorphine; Blood Pressure; Blood-Brain Barrier; Bromocriptine; Dogs; Domperidone; Female; Hydrocortisone; Male; Receptors, Dopamine; Sulpiride | 1986 |
[Interaction of opioid peptides and the dopaminergic system in the myenteric plexus of the guniea pig ileum].
Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Endorphins; Guinea Pigs; Haloperidol; Hydroxydopamines; Ileum; In Vitro Techniques; Myenteric Plexus; Naloxone; Oxidopamine; Receptors, Dopamine | 1987 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning | 1988 |
Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Electroencephalography; Electromyography; Haloperidol; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sleep; Sleep, REM; Wakefulness | 1988 |
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System | 1985 |
The dopamine hypothesis.
Topics: Apomorphine; Bromocriptine; Humans; Psychoses, Substance-Induced | 1988 |
D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Catalepsy; Male; Mice; Molindone; Motor Activity; Receptors, Dopamine | 1988 |
[The yawning behavior of rats following application of dopaminergic agonists--dose and time effect relationship].
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Lisuride; Male; Rats; Rats, Inbred Strains; Time Factors; Yawning | 1988 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea Pigs; Haloperidol; Lisuride; Morphine; Myoclonus; Naloxone; Scopolamine; Tremorine | 1986 |
Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Haloperidol; Mice; Nomifensine; Posture; Pyridazines; Stereotyped Behavior; Sulpiride; Time Factors | 1986 |
[Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Blood Pressure; Bromocriptine; Dihydroergotoxine; Domperidone; Double-Blind Method; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Random Allocation; Receptors, Dopamine | 1987 |
Effects of dopaminergic drugs on plasma levels of steroid hormones in conscious dogs.
Topics: Animals; Apomorphine; Bromocriptine; Dogs; Domperidone; Dopamine; Female; Haloperidol; Hydrocortisone; Male; Progesterone; Radioimmunoassay; Receptors, Dopamine; Sex Factors; Testosterone | 1986 |
Evidence for dopaminergic binding sites in the human adrenal cortex.
Topics: Adrenal Cortex; Adult; Aged; Apomorphine; Binding, Competitive; Bromocriptine; Domperidone; Dopamine; Epinephrine; Female; Humans; Ketanserin; Male; Metoclopramide; Middle Aged; Receptors, Dopamine; Spiperone; Sulpiride; Time Factors | 1986 |
Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Dopamine; Drug Interactions; Male; Nialamide; Nucleus Accumbens; Rats; Rats, Inbred Strains; Stereotyped Behavior; Trifluoperazine | 1986 |
[Effect on morphine hyperthermia of dopaminergic agents].
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Drug Interactions; Fever; Haloperidol; Male; Methotrimeprazine; Morphine; Naloxone; Rats; Rats, Inbred Strains; Rectum; Time Factors | 1985 |
Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cebus; Dextroamphetamine; Dopamine; Ergolines; Haloperidol; Humans; Mastication; Pergolide; Receptors, Dopamine; Stereotyped Behavior | 1985 |
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Nomifensine; Pyridines | 1985 |
[Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Haloperidol; Levodopa; Male; Pituitary Gland; Rats; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors | 1985 |
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
Topics: Animals; Apomorphine; Bromocriptine; Corpus Striatum; Hydroxydopamines; Kainic Acid; Male; Motor Activity; Muscle Denervation; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1985 |
Myoclonus induced by intermittent light stimulation in the baboon: neurophysiological and neuropharmacological approaches.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Animals; Anticonvulsants; Apomorphine; Bromocriptine; Cerebral Cortex; Electroencephalography; Electromyography; Electrophysiology; Evoked Potentials, Visual; gamma-Aminobutyric Acid; Light; Myoclonus; Papio; Periodicity; Piribedil | 1986 |
Association of spontaneous and dopaminergic-induced yawning and penile erections in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Male; Penis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reflex; Time Factors | 1985 |
Reduced sensitivity of synaptosomal dopamine autoreceptors following increase in synaptosomal dopamine synthesis.
Topics: Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; In Vitro Techniques; Lisuride; Male; Rats; Receptors, Dopamine; Synaptosomes | 1985 |
The role of dopamine in the formation of gastric ulcers in rats.
Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride | 1985 |
The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
Topics: Animals; Apomorphine; Blood Pressure; Bromocriptine; Carotid Arteries; Cats; Dopamine; Drug Interactions; Femur; Nomifensine; Phenoxybenzamine; Piperazines; Piribedil; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Sulpiride; Vasodilation | 1985 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Clozapine; Ergolines; Haloperidol; Humans; Male; Rats; Stereotyped Behavior; Time Factors | 1980 |
Metabolite involvement in bromocriptine-induced circling behaviour in rodents.
Topics: Amphetamine; Animals; Apomorphine; Biotransformation; Bromocriptine; Desipramine; Female; Hydroxydopamines; Male; Medial Forebrain Bundle; Methyltyrosines; Mice; Motor Activity; Nomifensine; Paralysis; Proadifen; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Reserpine; Sleep; Zoxazolamine | 1980 |
Central monoamine synapses as sites of action for ergot drugs.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Binding, Competitive; Brain; Bromocriptine; Catecholamines; Ergolines; Ergot Alkaloids; Male; Mice; Rats; Receptors, Neurotransmitter | 1980 |
Anorectic effect of lisuride and other ergot derivatives in the rat.
Topics: Animals; Apomorphine; Appetite Depressants; Bromocriptine; Dose-Response Relationship, Drug; Eating; Ergolines; Ergot Alkaloids; Haloperidol; Humans; Lisuride; Male; Motor Activity; Pimozide; Rats; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1980 |
Differential behavioral and biochemical effects of four dopaminergic agonists.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Haloperidol; Male; Methyltyrosines; Mice; Motor Skills; Piribedil | 1980 |
Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation.
Topics: Adrenergic Agonists; Aggression; Animals; Apomorphine; Bromocriptine; Haloperidol; Humans; Male; Piribedil; Rats; Receptors, Dopamine; Sleep Deprivation; Sleep, REM | 1981 |
The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Body Temperature Regulation; Brain; Bromocriptine; Female; Hydroxydopamines; Kinetics; Levodopa; Male; Mice; Mice, Inbred Strains; Neurons; Norepinephrine; Piribedil | 1981 |
Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Imidazolines; Male; Mice; Motor Activity; Prazosin; Receptors, Dopamine; Spiperone; Tetrahydronaphthalenes; Yohimbine | 1981 |
Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Fenclonine; Haloperidol; Humans; Male; Methyldopa; Methyltyrosines; Rats; Stereotyped Behavior; Stimulation, Chemical | 1982 |
Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum.
Topics: Afferent Pathways; Animals; Apomorphine; Biological Transport, Active; Bromocriptine; Cerebral Cortex; Dopamine; Glutamates; Glutamic Acid; Male; Nerve Endings; Rats; Receptors, Dopamine; Sodium | 1982 |
Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Apomorphine; Benzazepines; Binding Sites; Bromocriptine; Butyrophenones; Cats; Caudate Nucleus; Dopamine; Electric Stimulation; Female; In Vitro Techniques; Male; Phentolamine; Receptors, Dopamine; Spiperone; Sulpiride; Tritium | 1983 |
Lack of relation between dopaminergic and gabaergic mechanisms in chick retina.
Topics: 4-Aminobutyrate Transaminase; Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Carboxy-Lyases; Chickens; Dopamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Light; Receptors, Dopamine; Retina; Transaminases | 1983 |
Influence of dopamine receptor agonists on gastric acid secretion induced by intraventricular administration of thyrotropin-releasing hormone in the perfused stomach of anaesthetized rats.
Topics: Anesthesia; Animals; Apomorphine; Bethanechol; Bethanechol Compounds; Bromocriptine; Drug Interactions; Gastric Acid; Injections, Intraventricular; Intubation, Gastrointestinal; Male; Methamphetamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1983 |
Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Cerebral Cortex; Dose-Response Relationship, Drug; Ergolines; Functional Laterality; Male; Pimozide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Self Stimulation; Spiperone; Sulpiride; Synaptic Transmission | 1983 |
Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
Topics: Acetylcholine; Afferent Pathways; Animals; Apomorphine; Bromocriptine; Bucladesine; Corpus Striatum; Culture Techniques; Dose-Response Relationship, Drug; Ergolines; gamma-Aminobutyric Acid; Male; Molindone; Muridae; Nucleus Accumbens; Receptors, Dopamine; Septal Nuclei; Sulpiride; Synaptic Transmission | 1983 |
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes | 1984 |
Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Ergolines; Female; Methods; Mice; Motor Activity; Receptors, Dopamine; Sulpiride | 1984 |
Dopaminergic stimulation of prolactin release.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cells, Cultured; Dopamine; Haloperidol; Male; Pituitary Gland; Prolactin; Rats; Receptors, Dopamine | 1980 |
Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cell Line; Clone Cells; Dopamine; Dose-Response Relationship, Drug; Mice; Pituitary Neoplasms; Prolactin | 1980 |
Coat color in intact and neurointermediate lobe-grafted agouti mice: effect of dopamine agonists and antagonists.
Topics: Age Factors; Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Butaclamol; Dopamine Antagonists; Female; Hair Color; Male; Mice; Mice, Inbred C3H; Pimozide; Piribedil; Pituitary Gland; Receptors, Dopamine; Sulpiride | 1982 |
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride | 1984 |
Influence of the dopaminergic agonists bromocriptine, piribedil and nomifensine on the sympathetic neural transmission in the nictitating membrane of the cat.
Topics: Animals; Apomorphine; Bromocriptine; Cats; Dopamine; In Vitro Techniques; Isoquinolines; Nictitating Membrane; Nomifensine; Phentolamine; Piperazines; Piribedil; Sympathetic Nervous System; Synaptic Transmission | 1981 |
The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; In Vitro Techniques; Male; Muscle Contraction; Nomifensine; Norepinephrine; Phentolamine; Piribedil; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Vas Deferens | 1981 |
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
Topics: Apomorphine; Brain; Bromocriptine; Humans; Levodopa; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Opioid; Thyrotropin-Releasing Hormone | 1983 |
Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Levodopa; Male; Muridae; Receptors, Dopamine; Synaptic Transmission | 1983 |
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dextroamphetamine; Dopamine; Female; Macaca mulatta; Male; Motor Activity; Piribedil; Receptors, Dopamine; Self Administration | 1984 |
Dopaminergic regulation of hatching in fish embryos.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Bromocriptine; Dopamine; Endopeptidases; Female; Fishes; Isoquinolines; Light; Metalloendopeptidases; Methyltyrosines; Pimozide; Time Factors; Zygote | 1983 |
Differential effects of dopaminergic agonists on food-reinforced operant behavior in the long-tailed macaque (Macaca fascicularis).
Topics: Animals; Apomorphine; Bromocriptine; Conditioning, Operant; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Food; Macaca fascicularis; Male; Nalidixic Acid; Naphthyridines; Reinforcement Schedule | 1983 |
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
Topics: Apomorphine; Bromocriptine; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Phenethylamines; Receptors, Dopamine; Selegiline; Synapses | 1983 |
Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
Topics: Animals; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Hypothyroidism; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Thyrotropin | 1984 |
Studies on the inhibitory effect of apomorphine and bromocryptine on basal and TRH induced level of TSH and PRL in hypothyroid rats under pentobarbiturate anesthesia.
Topics: Anesthesia; Animals; Apomorphine; Bromocriptine; Hypothyroidism; Male; Pentobarbital; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Effects of catecholaminergic agonists and antagonists on serum gonadotropin concentrations and ovulation in goldfish: evidence for specificity of dopamine inhibition of gonadotropin secretion.
Topics: Animals; Apomorphine; Bromocriptine; Cyprinidae; Dopamine; Female; Goldfish; Gonadotropin-Releasing Hormone; Gonadotropins; Metoclopramide; Octopamine; Ovulation; Phentolamine; Pimozide; Propranolol | 1984 |
Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.
Topics: Animals; Apomorphine; Bromocriptine; Iontophoresis; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Tegmentum Mesencephali | 1984 |
Differential effects on phrenic output of two dopamine agonists, apomorphine and bromocriptine.
Topics: Action Potentials; Animals; Apomorphine; Bromocriptine; Carotid Body; Decerebrate State; Denervation; Dogs; Haloperidol; Phrenic Nerve; Receptors, Dopamine; Respiration; Time Factors; Vagotomy | 1984 |
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.
Topics: Adult; Apomorphine; Bromocriptine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male | 1983 |
Spontaneous eye-blink rates and dopaminergic systems.
Topics: Animals; Apomorphine; Blinking; Bromocriptine; Diazepam; Dopamine; Dose-Response Relationship, Drug; Macaca mulatta; Sulpiride; Time Factors | 1983 |
Dopaminergic agonists increase [3H]estradiol binding in hypothalamus of female rats, but not of males.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Estradiol; Female; Hypothalamus; In Vitro Techniques; Male; Rats; Sex Factors; Tritium | 1983 |
The inhibitory effect of dopaminomimetics on nerve stimulation-induced vasoconstriction of the cat's carotid artery.
Topics: Animals; Apomorphine; Bromocriptine; Carotid Arteries; Cats; Dopamine; Electric Stimulation; Nictitating Membrane; Receptors, Dopamine; Sympathetic Nervous System; Vasoconstriction | 1983 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Behavioral effects of dopamine agonists across the estrous cycle in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Estrus; Female; Humans; Motor Activity; Pregnancy; Rats; Self Stimulation; Stereotyped Behavior | 1980 |
Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Caudate Nucleus; Ergolines; Lisuride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1981 |
Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
Topics: Adenoma; Adult; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1982 |
Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
Topics: Agonistic Behavior; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Female; Humans; Male; Motor Activity; Piperazines; Piribedil; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Thyrotropin-Releasing Hormone | 1982 |
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Topics: Animals; Apomorphine; Bromocriptine; Butyrophenones; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Humans; Levodopa; Male; Muridae; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1982 |
Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Topics: Animals; Apomorphine; Binding, Competitive; Bromocriptine; Cells, Cultured; Domperidone; Dopamine; Kinetics; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thyrotropin | 1983 |
Bromocriptine inhibits 2-deoxy-D-glucose-stimulated gastric acid secretion in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Deoxy Sugars; Deoxyglucose; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Gastric Acid; Male; Rats; Rats, Inbred Strains; Vagus Nerve | 1983 |
Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
Topics: Acetylcholine; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Depression, Chemical; Dopamine; Haloperidol; Male; Rabbits; Receptors, Dopamine; Time Factors | 1983 |
Dopaminergic receptors in the modulation of seizures in the Mongolian gerbil.
Topics: Animals; Anticonvulsants; Apomorphine; Bromocriptine; Female; Gerbillinae; Male; Receptors, Dopamine; Seizures | 1983 |
A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine; Dopamine Antagonists; Female; In Vitro Techniques; Kidney; Male; Metoclopramide; Rats; Receptors, Dopamine; Regional Blood Flow; Vasodilation | 1980 |
Differential effects of dopamine agonists in mature and immature rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Humans; Levodopa; Male; Motor Activity; Rats; Scopolamine; Stereotyped Behavior; Sympathomimetics | 1981 |
Presynaptic effects of tetrahydropapaveroline on striatal dopaminergic neurons.
Topics: Animals; Apomorphine; Benztropine; Bromocriptine; Caudate Nucleus; Dopamine; Female; Haloperidol; In Vitro Techniques; Male; Neurons; Papaverine; Putamen; Rabbits; Synapses; Tetrahydropapaveroline | 1982 |
Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
Topics: Animals; Apomorphine; Brain Chemistry; Bromocriptine; Debrisoquin; Dopamine; Homovanillic Acid; Male; Phenylacetates; Rats; Rats, Inbred Strains | 1982 |
Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine; Electric Stimulation; Endorphins; Female; Flupenthixol; In Vitro Techniques; Naloxone; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Tetrodotoxin; Vasopressins | 1982 |
A mechanographic method for measurement of locomotor activity in rats. Effects of dopaminergic drugs and electric stimulation of the brainstem.
Topics: Animals; Apomorphine; Brain Stem; Bromocriptine; Dose-Response Relationship, Drug; Electric Stimulation; Locomotion; Male; Motor Activity; Neurophysiology; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine | 1982 |
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei | 1982 |
Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood of dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of en
Topics: Animals; Apomorphine; Bromocriptine; Dogs; Gastrointestinal Hormones; Gastrointestinal Motility; Haloperidol; Hypotension; Muscle Relaxation; Receptors, Dopamine; Vasoactive Intestinal Peptide; Vomiting | 1982 |
Aging and the regulation of striatal dopaminergic mechanisms in mice.
Topics: Aging; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Haloperidol; Humans; Male; Mice; Mice, Inbred C57BL; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Time Factors | 1981 |
Beneficial effects of lisuride in Meige disease.
Topics: Apomorphine; Bromocriptine; Ergolines; Female; Humans; Lisuride; Lymphedema; Male; Middle Aged | 1982 |
Dopaminergic agonists and conditioned avoidance response in normoxic or hypoxic rats.
Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Bromocriptine; Dopamine; Female; Hypoxia; Piribedil; Rats | 1981 |
Parkinson's disease: new treatments.
Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus | 1981 |
3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
Topics: 4-Butyrolactone; Animals; Apomorphine; Brain; Bromocriptine; Dextroamphetamine; Dopamine; Kinetics; Lisuride; Male; Mice; Norepinephrine; Normetanephrine; Pargyline; Receptors, Dopamine | 1981 |
Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Topics: Animals; Apomorphine; Bromocriptine; Cells, Cultured; Dopamine; Female; Kinetics; Pituitary Gland; Pregnancy; Prolactin; Rats | 1981 |
Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
Topics: Animals; Apomorphine; Bromocriptine; Levodopa; Male; Metoclopramide; Prolactin; Rats; Serotonin | 1981 |
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine | 1981 |
On the stereochemistry of dopaminergic ergoline derivatives.
Topics: Apomorphine; Bromocriptine; Dopamine; Ergolines; Molecular Conformation; Stereoisomerism | 1981 |
Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Brain; Bromocriptine; Choline; Corpus Striatum; Dopamine; Female; Rats; Stimulation, Chemical; Time Factors | 1981 |
Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
Topics: Acromegaly; Adenoma; Adult; Apomorphine; Breast Neoplasms; Bromocriptine; Cells, Cultured; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sympathomimetics | 1981 |
Influence of dopamine and dopaminergic agonists on relaxation of isolated rabbit ileum induced by sympathetic nerve stimulation.
Topics: Animals; Apomorphine; Bromocriptine; Cocaine; Dopamine; Electric Stimulation; Ileum; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nomifensine; Norepinephrine; Rabbits; Sulpiride; Sympathetic Nervous System; Yohimbine | 1981 |
Stimulation of 3H-apomorphine binding by dopamine and bromocriptine.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Binding Sites; Binding, Competitive; Brain; Bromocriptine; Dopamine; In Vitro Techniques; Rats; Receptors, Dopamine | 1980 |
Responsiveness of nigral neurons to the stimulation of striatal dopaminergic receptors in the rat.
Topics: Animals; Apomorphine; Bromocriptine; Corpus Striatum; Male; Neural Pathways; Neurons; Rats; Receptors, Dopamine; Stimulation, Chemical; Substantia Nigra; Time Factors | 1980 |
Effect of BCH 325 (Pro-D-Phe-Pro-Gly) on central dopaminergic functions.
Topics: Amino Acid Sequence; Animals; Apomorphine; Bromocriptine; Dopamine; Endorphins; Female; In Vitro Techniques; Molecular Sequence Data; Motor Activity; Nucleus Accumbens; Peptide Fragments; Potassium; Psychotropic Drugs; Rats; Rats, Wistar; Reserpine; Stimulation, Chemical; Synaptic Transmission; Yawning | 1995 |
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
Topics: Animals; Apomorphine; Azepines; Bromocriptine; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 1995 |
Possible sites of dopaminergic inhibition of gonadotropin release from the pituitary of a teleost fish, tilapia.
Topics: Animals; Apomorphine; Arachidonic Acid; Bromocriptine; Calcimycin; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Diglycerides; Dopamine; Dopamine Agonists; Ergolines; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Ionomycin; Pituitary Gland; Quinpirole; Signal Transduction; Tilapia | 1995 |
Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Female; Male; Mice; Motor Activity; Penile Erection; Pyrazoles; Quinolines; Rats; Rats, Wistar; Receptors, Neurotensin; Stereotyped Behavior; Yawning | 1994 |
Individual motor activity--relationships to dopaminergic responses.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred A; Motor Activity; Phenotype; Stereotyped Behavior | 1994 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |
Dopaminergic stimulation of estrogen receptor binding in vivo: a reexamination.
Topics: Adrenalectomy; Animals; Apomorphine; Brain; Bromocriptine; Cell Membrane; Cell Nucleus; Ditiocarb; Dopamine; Estradiol; Female; Hypothalamus; Kinetics; Metoclopramide; Ovariectomy; Pituitary Gland, Anterior; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Estrogen | 1994 |
Effects of microgram doses of haloperidol on open-field behavior in mice.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity | 1996 |
Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Cholinesterase Inhibitors; Cholinesterases; Dopamine Agonists; Drug Interactions; Male; Mastication; Rats; Rats, Sprague-Dawley; Tacrine | 1997 |
D1 dopamine receptor activity of anti-parkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles | 1997 |
Brain-mediated protective interactions of histaminergic H2 and dopaminergic systems in rats.
Topics: Animals; Apomorphine; Bromocriptine; Cimetidine; Domperidone; Dopamine Agonists; Dopamine Antagonists; Female; Histamine H2 Antagonists; Male; Peptic Ulcer Hemorrhage; Rats; Rats, Wistar; Stomach Ulcer; Sulpiride | 1997 |
The effects of dopaminergic and adrenergic drugs on twitch response of guinea-pig common bile duct.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Bromocriptine; Common Bile Duct; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth | 1997 |
Effects of lead exposure on licking and yawning behaviour in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cholinesterase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Lead Poisoning; Male; Organometallic Compounds; Physostigmine; Poisons; Rats; Rats, Wistar; Yawning | 1998 |
Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice.
Topics: Amlodipine; Animals; Apomorphine; Benzazepines; Bromocriptine; Calcium Channel Blockers; Diltiazem; Dopamine Antagonists; Female; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Mice; Morphine; Motor Activity; Nicardipine; Time Factors; Verapamil | 1999 |
Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells.
Topics: Alkylating Agents; Animals; Apomorphine; Bromocriptine; Cell Line; Depression, Chemical; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Phenoxybenzamine; Prolactin; Rats; Secretory Rate; Stimulation, Chemical | 1999 |
Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Cell Membrane; Corpus Striatum; Domperidone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Male; Oxidopamine; Piperazines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes; Tritium | 1999 |
TH protein and mRNA in nigrostriatal dopaminergic neurons are down-regulated by continuous but not intermittent apomorphine.
Topics: Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Drug Administration Schedule; Functional Laterality; Gene Expression Regulation, Enzymologic; Male; Mesencephalon; Neurons; Protein Biosynthesis; Rats; Rats, Wistar; RNA, Messenger; Substantia Nigra; Time Factors; Transcription, Genetic; Tyrosine 3-Monooxygenase | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Bromocriptine; Butaclamol; Chlorpromazine; CHO Cells; Clozapine; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Haloperidol; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Phenethylamines; Piperidines; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Dopamine D2; Recombinant Fusion Proteins; Sodium; Spiperone; Structure-Activity Relationship; Sulpiride; Transfection; Tyramine | 2001 |
Inhibitory mechanism of bromocriptine on catecholamine release evoked by cholinergic stimulation and membrane depolarization from the rat adrenal medulla.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenal Medulla; Animals; Apomorphine; Bromocriptine; Calcium Channel Agonists; Catecholamines; Cholinergic Agonists; Dimethylphenylpiperazinium Iodide; Dopamine Agonists; Electrophysiology; In Vitro Techniques; Indoles; Male; Membranes; Muscarinic Agonists; Nicotinic Agonists; Perfusion; Potassium; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 2002 |
Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation.
Topics: Animals; Apomorphine; Benzazepines; Blood Pressure; Bromocriptine; Carotid Artery, External; Dogs; Dopamine; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Haloperidol; Heart Rate; Male; Tyramine; Vagotomy; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Involvement of transmitters in pituitary adenylate cyclase-activating polypeptide-induced hyperthermia.
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fever; Haloperidol; Male; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Wistar; Time Factors | 2003 |
A new approach to finding specific dopamine D4 receptor agonists.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Apomorphine; Blotting, Western; Bromocriptine; Cloning, Molecular; Clozapine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; In Vitro Techniques; Male; Molecular Sequence Data; Muscle Contraction; Phenethylamines; Prazosin; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Vas Deferens | 2005 |
Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens.
Topics: Animals; Apomorphine; Astrocytes; Bromocriptine; Cell Communication; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Extracellular Fluid; Glucose; Lactic Acid; Male; Microdialysis; Neurons; Nucleus Accumbens; Potassium; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium Channel Blockers; Up-Regulation | 2007 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Astrocytes; Brain-Derived Neurotrophic Factor; Bromocriptine; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Indoles; Mice; Mice, Inbred ICR; Nerve Growth Factor; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2010 |